SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis-论文-万方医学网

SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis

导出原文传递

翻译打印收藏纠错

作者： Boettler T. ^[1] ; Csernalabics B. ^[2] ; Salie H. ^[3] ; Luxenburger H. ^[4] ; Wischer L. ; Salimi Alizei E. ; Zoldan K. ; Krimmel L. ; Bronsert P. ; Schwabenland M. ; Prinz M. ; Mogler C. ; Neumann-Haefelin C. ; Thimme R. ; Hofmann M. ; Bengsch B.

作者单位： Department of Medicine II (Gastroenterology Hepatology Endocrinology and Infectious Diseases ^[1] Institute for Surgical Pathology Freiburg University Medical Center University of Freiburg ^[2] Institute of Neuropathology and Center for Basics in NeuroModulation (NeuroModulBasics) Faculty of ^[3] Institute of Pathology TUM School of Medicine Technical University of Munich ^[4]

关键词 Autoimmune hepatitis CD8+ T cell COVID-19 Immunosuppression Vaccination Virus-specific T cell

发布时间 2022-10-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除